BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pfenex Inc. 

5501 Oberlin Drive

San Diego  California  92121  U.S.A.
Phone: 858-352-4400 Fax: 858-352-4602


SEARCH JOBS




Industry
Biotechnology






 Company News
San Diego Biotech Pfenex Inc. Slashes Proposed Range To $8 A Share, Eyes $65 Million In IPO Debut 7/18/2014 7:09:39 AM
San Diego's Pfenex Inc. Files For A $75 Million IPO To Fund Development Of Wet AMD Drug 6/6/2014 6:35:02 AM
Pfenex Inc. Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine 12/17/2013 9:57:27 AM
Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of Its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of Its Anthrax Vaccine 11/5/2013 9:29:44 AM
Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP Production Process for a Second Key Malaria Antigen 10/29/2013 12:01:49 PM
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option With Pfenex Inc. to Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine 10/1/2013 9:32:12 AM
Pfenex Inc. Strain Engineering to Host "Strategies for Accelerating Preclinical Development of Vaccines and Therapeutic Proteins" Seminar on Aug. 20th in Boston 6/19/2013 11:57:07 AM
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine 4/30/2013 10:21:06 AM
Pfenex Inc. and Agila Biotech Private Limited Announce Joint Venture to Develop Biosimilar Products for the Global Market 4/16/2013 9:39:39 AM
Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Capacity Expansion for cGMP CRM197 Production 1/16/2013 9:10:16 AM
1234